After breast cancer at 30, Aisha shares her journey through motherhood, a double mastectomy, body image struggles and the challenges of survivorship.
|Videos|December 21, 2017
Julie Nangia Discusses the Impact of Hair Loss
Author(s)Julie Nangia, M.D.
Julia Nangia, M.D., assistant professor at Baylor College of Medicine, discusses the impact that chemotherapy-related hair loss can have on patients with breast cancer.
Advertisement
Julia Nangia, M.D., assistant professor at Baylor College of Medicine, discusses the impact that chemotherapy-related hair loss can have on patients with breast cancer.
When a woman loses her hair, that may not be all that is lost. Hair loss also causes a loss of anonymity that a person is sick. But luckily, hair-preserving cooling caps are becoming more common for patients with cancer.
Advertisement
Related to this article
Diagnosed with stage 4 breast cancer weeks after giving birth, Eileen Carter explains why getting a second opinion changed the course of her care.
Martha Carlson reflects on her 11 years with metastatic breast cancer and explores how resilience, purpose and the stories we tell ourselves shape the cancer experience.
A study found that 1 in 9 older cancer survivors developed a second cancer, highlighting why routine screening remains important beyond five years.
A study found that sentinel lymph node biopsy rarely missed remaining cancer in patients with locally advanced breast cancer whose lymph nodes responded to chemotherapy before surgery.
Lower income, later diagnosis and gaps in treatment drove most of the excess deaths among rural patients, according to new research.
The FDA has cleared TumorSight Risk, software that uses a patient's existing breast MRI, pathology and clinical information to estimate the chance that early HR-positive, HER2-negative breast cancer will come back within five and 10 years.
Emma Halligan found connection at a free New Jersey retreat for women with cancer, which held its annual walk and 5K on Oct. 17.
Advertisement
Advertisement
Trending on CURE
1
New Myelofibrosis Guidelines Back Wider Gene Testing at Diagnosis
2
FDA Clears AI Tool Using MRI to Gauge Breast Cancer Recurrence
3
FDA Approves Jemperli for dMMR Locally Advanced Rectal Cancer
4
Why Cancer Screening Remains Important for Long-Term Cancer Survivors
5